Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000102

Chairperson & CEO sold 9,500 shares at an average $531.69 ($5,051,035)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

9 lines
Date Transaction Shares Price Value Owned after D/I
2026-07-20 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $135.42 $1,286,490 333,943 I
2026-07-20 Sale : show line 2 in the form 10b5-1 −1,831 $529.19 $968,945 332,112 I
2026-07-20 Sale : show line 3 in the form 10b5-1 −960 $529.85 $508,657 331,152 I
2026-07-20 Sale : show line 4 in the form 10b5-1 −1,660 $531.08 $881,588 329,492 I
2026-07-20 Sale : show line 5 in the form 10b5-1 −1,874 $532.07 $997,105 327,618 I
2026-07-20 Sale : show line 6 in the form 10b5-1 −1,686 $533.03 $898,683 325,932 I
2026-07-20 Sale : show line 7 in the form 10b5-1 −889 $534.13 $474,838 325,043 I
2026-07-20 Sale : show line 8 in the form 10b5-1 −520 $535.20 $278,306 324,523 I
2026-07-20 Sale : show line 9 in the form 10b5-1 −80 $536.41 $42,913 324,443 I
Open-market sales · 9,500 sh · avg $531.69 · $5,051,035

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-07-20 Exercise or conversion : show line 10 in the form 10b5-1 Stock Option −9,500 312,910 I
Loading xslF345X06/primarydocument.xml…